SCHEMBL30007560

SCHEMBL30007560

CS(=O)(=O)c1ccc(-c2cnc3[nH]nc(C(=O)N4CCC(c5ccccc5)CC4)c3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
SCD5 Q86SK9 7/20 0.42
SCD O00767 3/20 0.42
EPHX1 P07099 1/20 0.41
EPHX2 P34913 1/20 0.41
KCNH2 Q12809 1/20 0.41
MAP4K1 Q92918 1/20 0.40
GAA P10253 2/20 0.40
KDM5A P29375 1/20 0.40
TACR3 P29371 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
RBP4 P02753 3/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007738 0.91 KDM5A (0.42) CA12CA1CA2CA7CA9
SCHEMBL30007265 0.84 AVPR1A (0.49) CA12CA1CA2CA7CA9
SCHEMBL30007741 0.81 CA12 (0.44) CA12CA1CA2CA7CA9
SCHEMBL30007692 0.78 GSK3A (0.51) GSK3AGSK3BKCNH2MAP4K1PRKAG1
SCHEMBL30007554 0.75 AVPR1A (0.47) CA12CA1CA2CA7CA9
SCHEMBL30007902 0.67 GSK3A (0.46) GSK3AGSK3BPRKAB2PRKAG1PRKAA2
SCHEMBL17514184 0.67 RAB9A (0.50) SCD5SCDALDH1A1LMNAMAPT
SCHEMBL17514218 0.67 RAB9A (0.50) SCD5SCDALDH1A1LMNAMAPT
SCHEMBL19349672 0.67 RAB9A (0.50) SCD5SCDALDH1A1LMNAMAPT
SCHEMBL14624308 0.66 GPR119 (0.51) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed